MedLogic Gobal Ltd has announced the Launch of LiquiBand Optima, an advanced topical cyanoacrylate skin adhesive that sets new standards for minor wound closure.
LiquiBand Optima contains the Octyl-Blend cyanoacrylate monomer that combines the fast setting wound closure properties of butyl-cyanoacrylates with the more flexible wound dressing capabilities of octyl-cyanoacrylates. This new formulation has a number of advantages, not only for the patient, but also aids the clinician in treating patient’s wounds quickly and safely.
LiquiBand Optima is a pre-assembled device that can be used straight from the pack and has a unique winged actuator that provides an easy ‘click-and-use’ functionality. This new precision applicator design allows precise control, thus enabling the clinician to perform quicker, safer and more precise wound closure that helps achieve excellent cosmetic results.
Unlike some competitor products, LiquiBand Optima is a no sting formulation making it ideal for use on younger patients and those who have fear of suture needles. The fast set time ofLiquiBand Optima of 10 seconds provides ease of use and safe, cosmetic wound closure. In addition, the microbial barrier and waterproof properties of the polymerized Octyl-Blendmonomer helps to protect the wound against infection. The Octyl-Blend formulation ofLiquiBand Optima allows the product to be stored at ambient temperature and does not require refrigerated storage (unlike some other marketed products).
Gordon Schofield, Marketing Manager of MedLogic commented that
LiquiBand Optima was developed as a result of our customer feedback and requests, and we are absolutely delighted with the clinicians and nurses responses to the new product during pre-launch clinical evaluations.